Philip Thompson
0000-0003-2086-6031
3 papers found
Refreshing results…
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia
A phase two study of high dose blinatumomab in Richter’s syndrome
Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia
Missing publications? Search for publications with a matching author name.